Dr Jean-Christophe EICHER
Cardiologue CHU de Dijon
glyphosines dans l'amylose cardiaque
Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis—A Clinical Feasibility Study.
Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis—A Clinical Feasibility Study